BNT163 / University of Pennsylvania, BioNTech  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BNT163 / BioNTech
NCT05432583: A Clinical Trial in Healthy Volunteers to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Recruiting
1
288
US
BNT163, Placebo
BioNTech SE
Genital Herpes Simplex Type 2
04/26
04/26

Download Options